0001562180-23-002584.txt : 20230307
0001562180-23-002584.hdr.sgml : 20230307
20230307175917
ACCESSION NUMBER: 0001562180-23-002584
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230303
FILED AS OF DATE: 20230307
DATE AS OF CHANGE: 20230307
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fox Jonathan C
CENTRAL INDEX KEY: 0001655016
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40236
FILM NUMBER: 23714166
MAIL ADDRESS:
STREET 1: C/O MYOKARDIA, INC.
STREET 2: 333 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Edgewise Therapeutics, Inc.
CENTRAL INDEX KEY: 0001710072
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 821725586
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3415 COLORADO AVE.
CITY: BOULDER
STATE: CO
ZIP: 80303
BUSINESS PHONE: 303-735-8373
MAIL ADDRESS:
STREET 1: 3415 COLORADO AVE.
CITY: BOULDER
STATE: CO
ZIP: 80303
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2023-03-03
false
0001710072
Edgewise Therapeutics, Inc.
EWTX
0001655016
Fox Jonathan C
C/O 3415 COLORADO AVE
BOULDER
CO
80303
true
false
false
false
Stock Option (Right to Buy)
9.43
2023-03-03
4
A
false
43731.00
0.00
A
2033-03-03
Common Stock
43731.00
43731.00
D
1/36th of the shares subject to the option vest each month beginning on March 3, 2023, subject to the Reporting Person continuing as a service provider through each vest date.
/s/ John R. Moore, Attorney-in-Fact for Fox Jonathan C
2023-03-07